VIRAL DIAGNOSTIC TEST KITS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-158660 | Health Care
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Viral Diagnostic Test Kits Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET
7.1 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA VIRAL DIAGNOSTIC TEST KITS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Abbott Laboratories (United States)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Autobio Diagnostics Co (China)
16.3 Certest Biotec S.L. (Spain)
16.4 CorisBioconcept SPRF (Belgium)
16.5 F. Hoffman La Roche, Ltd. (Switzerland)
16.6 VIDIA s.r.o (Czechia)
16.7 Hologic Inc. (United States)
16.8 bioMerieux SA (France)
16.9 Quidel Corporation (United States)
16.10 Thermo Fisher Scientific (United States)
16.11 Becton, Dickinson and Company (United States)
16.12 Luminex Corporation (United States)
16.13 Nectar Lifesciences (India)
16.14 Cortez Diagnostics (United States)
16.15 Bundi International Diagnostics (Nigeria)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeInfluenza Test Kits
Hepatitis Test Kits
Human Immunodeficiency Virus Test Kits
Respiratory Syncytial Virus Test Kits
Other
By End Users
Diagnostic & Clinical Laboratories
Academic & Research Institutes
Contract Research Organizations
Others
By Sales Channel
Online
Offline
By Test Type
Traditional Tests {Cell Culture Test Complement Fixation Test (CFT) Haemagglutination Inhibition Test Others}
Rapid Tests {Nucleic Acid Amplification Test (NAAT) Immunoassay Test Next Generation Sequencing (NGS) Mass Spectrometry}
Companies
Abbott Laboratories (United States)
Autobio Diagnostics Co (China)
Certest Biotec S.L. (Spain)
CorisBioconcept SPRF (Belgium)
F. Hoffman La Roche, Ltd. (Switzerland)
VIDIA s.r.o (Czechia)
Hologic Inc. (United States)
bioMerieux SA (France)
Quidel Corporation (United States)
Thermo Fisher Scientific (United States)
Becton, Dickinson and Company (United States)
Luminex Corporation (United States)
Nectar Lifesciences (India)
Cortez Diagnostics (United States)
Bundi International Diagnostics (Nigeria)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.